King Minos hall III
King Minos hall III
General assembly
Διαλειμα - Καφές
Clinical Nephrology
N.3A. Cardiovascular morbidity in CKD
1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias
2. HIF inhibitors: their place in clinical practice Athena Gompou
3. Update in the management of hyperkalaemia Evdokia Efthymiou
N.3B. Renal dietetics
1. TBC
2. TBC
3. TBC
Β. Κολοβός, Δ. Κιρμιζής
General assembly
Clinical Nephrology
N.4A. IgA nephropathy
1. The role of B cells and BAFF/APRIL Dimitrios Bakoulis
2. New and emerging therapies in IgA nephropathy Panagiotis Kompotiatis
3. How should I manage the patient with IgA nephropathy Maria Stangou
Κ. Ψούνης, Π. Καλογερόπουλος
Ε. Σταυρινού
Θ. Ελευθεριάδης
Μ. Στάγκου
Διαλειμμα - Καφές
Cardiovascular morbidity
Ε. Πάνου
Ε. Ιντζεβίδου
Ι. Δρούλιας
N.6A. Hypertension
1. Management of hypertension in patients with CKD Georgios Hatzivasiliou
2. Resistant hypertension Vasileios Raptis
3. Use of diuretics in CKD: benefits and risks Eleni Intzevidou
4. Hypertension in dialysis Antonios Zagorianakos
Π. Νέννες, Η. Κυρίτσης
Διαλειμμα - Καφές
Cardiovascular morbidity
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Π. Μανωλακάκη
Γ. Χατζηβασιλείου
Π. Νέννες
Α. Βαϊνάς. Σ. Ψαριανός
Cardiovascular morbidity
Β. Γαλανάκη, Π. Μακρή,
N.3A. Cardiovascular morbidity in CKD
1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias
2. HIF inhibitors: their place in clinical practice Athena Gompou
3. Update in the management of hyperkalaemia Evdokia Efthymiou
Β. Ράπτης
Δ. Μωϋσιάδης
Γ. Βολιώτης
Close
Approved by:
Accreditation: